Anti-coagulants Equal in Aortic Valve Replacement
from MedPage Today
Bivalirudin isn't any better than unfractionated heparin in transcatheter aortic valve replacement, the BRAVO 3 trial showed. Anti-coagulation with the newer, more expensive agent did not significantly lower rates of major bleeding at 48 hours,
Thierry Lefevre, MD
, of Institut Hospitalier Jacques Cartier in Massy, France, and colleagues reported at the Transcatheter Cardiovascular Therapeutics meeting.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063